Quest Diagnostics (DGX) Invested Capital (2009 - 2026)

Quest Diagnostics has reported Invested Capital for 18 years, with the latest figure at $10.0 million in Q2 2026.

• Quarterly Invested Capital fell 98.02% year-over-year to $10.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (down 11.05% YoY) and the FY2025 annual result came in at $504.0 million, down 16.28% from the prior year.
• Invested Capital declined to $10.0 million in Q2 2026 per DGX's latest filing, from $503.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $906.0 million in Q1 2024 and troughed at $1.0 million in Q1 2025.
• A 5-year average of $326.6 million and a median of $403.5 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2025 and 2026: Invested Capital slumped 99.89% in 2025, then soared 50200.0% in 2026.
• Over 5 years, Invested Capital stood at $2.0 million in 2022, then surged by 15050.0% to $303.0 million in 2023, then jumped by 98.68% to $602.0 million in 2024, then retreated by 16.28% to $504.0 million in 2025, then tumbled by 98.02% to $10.0 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $10.0 million, $503.0 million, and $504.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.